Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer’s disease in older adults.

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Studies have long warned that blows to the head may raise the risk of neurodegenerative conditions. Now, scientists believe ...

In this prognostic study, with the use of a statistical modeling approach, the Florey Dementia Index was developed and validated to ...

For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral neuropathy, especially in the hands and feet, is a common side effect.

Higher green tea consumption significantly reduces cerebral white matter lesions in older adults, offering potential ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...